GlaxoSmithKline is a science-led global healthcare company with a mission: they want to help people to do more, feel better, live longer.

On March 2, 2015, they completed a 3-part transaction with Novartis which reshapes their business.

GlaxoSmithKline acquired Novartis’s vaccines business (excluding influenza vaccines) and combined the Consumer Healthcare businesses to create a new company. By substantially strengthening Vaccines and Consumer Healthcare, they can deliver far-reaching benefits to patients and consumers, and further value to shareholders. In addition, Novartis acquired their marketed Oncology portfolio.